Remove 2017 Remove Health Technology Remove Leadership Remove Life Science
article thumbnail

Digital Therapeutics Alliance and Healthware Group launched their first DTx Policy Report and website dedicated to helping advance equitable access and adoption of safe and effective DTx and Digital Medical Devices

Digital Health Global

The report details fit-for-purpose appraisal criteria being applied in countries with formal frameworks in place, analyzing requirements through the common lens of the Health Technology Assessment (HTA) Core Model®.

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. & in 2017 to as low as $0.19 in 2011 and $5.00 on June 30, 2023.